XML 73 R46.htm IDEA: XBRL DOCUMENT v3.4.0.3
Stock-Based Compensation (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Unrecognized expense related to stock awards $ 8,300,000   $ 5,700,000
Stock Options, Shares      
Outstanding at beginning of period (in shares) 569,342    
Granted (in shares) 0    
Exercised (in shares) (195,935)    
Forfeited (in shares) (2,000)    
Expired (in shares) (8,200)    
Outstanding at end of period (in shares) 363,207   569,342
Stock Options, Weighted- Average Exercise Price      
Outstanding at beginning of period (in dollars per share) $ 19.35    
Granted (in dollars per share) 0.00    
Exercised (in dollars per share) 27.99    
Forfeited (in dollars per share) 12.22    
Expired (in dollars per share) 24.85    
Outstanding at end of period (in dollars per share) 14.60   $ 19.35
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]      
Weighted-average grant date fair value of options granted (in dollars per share) $ 0.00 $ 0.00  
Total fair value of options that vested $ 0 $ 0  
Total intrinsic value of options exercised $ 853,000 $ 1,138,000  
Chairman, President, and Chief Executive Officer [Member] | Common Stock [Member] | Achieves a specified improvement in total shareholder return at the end of 2016 compared to 2011 and she remains an employee [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares received if achieves specified improvement in total shareholders return (in shares) 135,000    
Chairman, President, and Chief Executive Officer [Member] | Common Stock [Member] | Achieves a specified improvement in total shareholder return at the end of 2014 compared to 2011 and she remains an employee [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares received if achieves specified improvement in total shareholders return (in shares) 35,000    
Chairman, President, and Chief Executive Officer [Member] | Common Stock [Member] | Achieves a specific performance target by the end of 2019 and she remains an employee [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares received if achieves specified improvement in total shareholders return (in shares) 53,859    
Chairman, President, and Chief Executive Officer [Member] | Common Stock [Member] | Achieves a specific performance target by the end of 2017 and she remains an employee [Member] [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares received if achieves specified improvement in total shareholders return (in shares) 17,953    
Executive Vice President and Chief Financial Officer [Member] | Common Stock [Member] | Achieved performance target for 2015 and 2016 [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based compensation arrangement by share-based payment award, purchase price of common stock $ 100,000    
Executive Vice President and Chief Financial Officer [Member] | Common Stock [Member] | Achieved performance target for 2015, 2016 and 2017 [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based compensation arrangement by share-based payment award, purchase price of common stock $ 275,000    
Restricted Stock and Performance Shares [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Period of time stock expense is expected to be recognized 1 year 10 months 24 days   1 year 4 months 24 days
Restricted Stock [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Expected quarterly dividends per share (in dollars per share) $ 0.22 $ 0.20  
Risk-free interest rate 1.00% 1.07%  
Restricted Stock, Shares      
Outstanding at beginning of period (in shares) 245,094    
Granted (in shares) 173,903    
Exercised (in shares) (178,574)    
Forfeited (in shares) 0    
Outstanding at end of period (in shares) 240,423   245,094
Restricted Stock, Weighted- Average Grant Date Fair Value      
Outstanding at beginning of period (in dollars per share) $ 24.81    
Granted (in dollars per share) 26.05 $ 19.93  
Exercised (in dollars per share) 23.13    
Forfeited (in dollars per share) 0.00    
Outstanding at end of period (in dollars per share) 26.96   $ 24.81
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]      
Weighted-average grant date fair value (in dollars per share) $ 26.05 $ 19.93  
Total fair value of restricted shares that vested $ 4,131,000 $ 6,005,000  
Performance Shares [Member] | Executive [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares granted (in shares) 79,619    
Shares exercised (in shares) 74,697    
Share-based compensation, weighted percentage assigned to achieving market targets 60.00%    
Share-based compensation, weighted percentage assigned to achieving performance targets 40.00%    
Share-based compensation, maximum number of shares awarded in year 1 (in shares) 165,628    
Share-based compensation, maximum number of shares awarded in year 2 (in shares) 168,258    
Share-based compensation, maximum number of shares awarded in year 3 (in shares) 147,031    
Performance period 3 years    
Market-Based Shares [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Risk-free interest rate 0.97% 1.00%  
Dividend yield 2.74% 2.87%  
Expected volatility 20.44% 18.73%  
Stock Options [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Aggregate intrinsic value of stock options outstanding $ 6,900,000    
Weighted-average remaining contract life 2 years 6 months 11 days    
Number of outstanding stock options with an exercise price greater than the closing price (in shares) 0    
Performance Equity Plan [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period 3 years    
Vesting rate 100.00%